These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11858508)

  • 1. Recurrent late fetal death in women with and without thrombophilia.
    Martinelli I; Taioli E; Cetin I; Mannucci PM
    Thromb Haemost; 2002 Feb; 87(2):358-9. PubMed ID: 11858508
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism.
    Simioni P; Tormene D; Prandoni P; Girolami A
    Thromb Haemost; 2001 Sep; 86(3):929. PubMed ID: 11583329
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.
    Grandone E; Margaglione M; Colaizzo D; Pavone G; Paladini D; Martinelli P; Di Minno G
    Haematologica; 2002 Feb; 87(2):177-81. PubMed ID: 11836168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foetal growth restriction in children with prothrombotic risk factors.
    von Kries R; Junker R; Oberle D; Kosch A; Nowak-Göttl U
    Thromb Haemost; 2001 Oct; 86(4):1012-6. PubMed ID: 11686317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
    Balogh I; Póka R; Losonczy G; Muszbek L
    Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistance.
    ten Cate AJ; van de Hoek YT; Reitsma PH; ten Cate H; Smits P
    Thromb Haemost; 2002 May; 87(5):919-20. PubMed ID: 12038799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks.
    Middeldorp S; van der Meer J; Hamulyák K; Büller HR
    Thromb Haemost; 2002 Feb; 87(2):360-1; author reply 361. PubMed ID: 11858509
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor V Leiden--the commonest molecular defect in arterial and venous thrombophilia in India.
    Ahmed RP; Gupta PK; Kannan M; Choudhry VP; Saxena R
    Thromb Res; 2003 Apr; 110(1):19-21. PubMed ID: 12877904
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency of selected thrombophilias in women with placental abruption.
    Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Constitutional thrombophilias: indications of the biological profile and therapeutic consequences].
    Trillot N; Rugeri L; Jude B
    Therapie; 1999; 54(4):413-8. PubMed ID: 10667107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death].
    Santoro R; Iannaccaro P; Sottilotta G
    Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Zotz RB
    Thromb Haemost; 2003 Jul; 90(1):77-85. PubMed ID: 12876629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic risk factors and arterial thrombotic disease.
    Reiner AP; Siscovick DS; Rosendaal FR
    Thromb Haemost; 2001 Apr; 85(4):584-95. PubMed ID: 11341490
    [No Abstract]   [Full Text] [Related]  

  • 20. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.
    Morrison ER; Miedzybrodzka ZH; Campbell DM; Haites NE; Wilson BJ; Watson MS; Greaves M; Vickers MA
    Thromb Haemost; 2002 May; 87(5):779-85. PubMed ID: 12038776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.